Skip to content

Drug interactions

Denosumab + Siponimod

Severity: Moderate

Denosumab and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Siponimod reduces circulating lymphocytes with effects lasting after discontinuation, and denosumab has been associated with serious infections. Combined use may increase infection risk.

What this interaction means in plain words

Denosumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Denosumab belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive pharmacodynamic effect: S1P receptor modulation sequesters lymphocytes while denosumab inhibits RANKL signalling in immune cells.

What to do

Monitor for infection and lymphocyte counts, including for weeks after siponimod is stopped. Treat infections early.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Denosumab and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Denosumab with Siponimod?

MediHelp rates the interaction as moderate. Denosumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Siponimod reduces circulating lymphocytes with effects lasting after discontinuation, and denosumab has been associated with serious infections. Combined use may increase infection risk.

How serious is the interaction between Denosumab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and lymphocyte counts, including for weeks after siponimod is stopped. Treat infections early.

What other medicines interact with Denosumab?

MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in